Learning Objectives:

  1. Identify several classes of glucose-lowering medications with proven benefits in improving cardiovascular outcomes.
  2. Be able to summarize key messages from current practice guidelines for patients with type 2 diabetes and cardiovascular disease.
  3. Understand the value of a coordinated team-based approach afforded by the Cardiometabolic Center of Excellence model.


Session date: 
01/27/2023 - 12:00pm to 1:00pm CST
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Mikhail Kosiborod, MD, FACC, FAHA